ArticleHPB surgery : a world journal of hepatic, pancreatic and biliary surgery2014
Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors.
Article in HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.
- Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review.Frontiers in oncology · 2021Pooled it
- The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact.Irish journal of medical science · 2018Pooled it
- A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine.Frontiers in oncology · 2022Article
- Oligometastatic Breast Cancer: How to Manage It?Journal of personalized medicine · 2021Review
- Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis.Journal of personalized medicine · 2021Article
- IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment.Frontiers in oncology · 2021Article
- Hepatectomy for Breast Cancer Metastasis and Sarcoma are more likely to have Adverse Outcomes than Hepatectomy for Primary Hepatocellular Cancer or for Colorectal Metastasis.Cancer medicine journal · 2020Article
- Surgical therapy for breast cancer liver metastases.Translational cancer research · 2020Review
- The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.Cancer medicine · 2020Article
- Local Treatment of Breast Cancer Liver Metastasis.Cancers · 2019Review
- Long-term survival and cure model following liver resection for breast cancer metastases.Breast cancer research and treatment · 2018Article
- Cure in metastatic breast cancer.Memo · 2018Review
- Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature.Surgical case reports · 2017Article
- Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Seminars in interventional radiology · 2017Review
- A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.Stem cell reviews and reports · 2017Review
- Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.Clinical & experimental metastasis · 2016Review
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.Annals of surgery · 2016Article
- Review
- Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature.Updates in surgery · 2015Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background. Breast cancer liver metastasis is a hematogenous spread of the primary tumour. It can, however, be the expression of an isolated recurrence. Surgical resection is often possible but controversial. Methods. We report on 29 female patients treated operatively due to isolated breast cancer liver metastasis over a period of six years. Prior to surgery all metastases appeared resectable. Liver metastasis had been diagnosed 55 (median, range 1-177) months after primary surgery. Results. Complete resection of the metastases was performed in 21 cases. The intraoperative staging did not confirm the preoperative radiological findings in 14 cases, which did not generally lead to inoperability. One-year survival rate was 86% in resected patients and 37.5% in nonresected patients. Significant prognostic factors were R0 resection, low T- and N-stages as well as a low-grade histopathology of the primary tumour, lower number of liver metastases, and a longer time interval between primary surgery and the occurrence of liver metastasis. Conclusions. Complete resection of metastases was possible in three-quarters of the patients. Some of the studied factors showed a prognostic value and therefore might influence indication for resection in the future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.